Cathie Wood's ARK Innovation Stocks Performance Guide: Verve Therapeutics (VERV)
VERV has no dividends
Table and Chart of VERV Performance
See what a $1,000 investment in VERV is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| VERV Returns | |
|---|---|
| Start Date | Jul-30-2021 |
| Start Price | $59.43 |
| End Date | Nov-28-2023 |
| End Price | $11.93 |
| # Prices | 29 |
| Min Date | Nov-28-2023 |
| Min Price | $11.93 |
| Max Date | Aug-31-2021 |
| Max Price | $69.96 |
| Total Return | -79.93% |
| Annualized Return | -48.54% |
| Current Value of $1,000 Purchase | $201 |
| Number Returns | 406 |
| Average Return | -27.92% |
| Number Profitable Returns | 75 |
| Percent Profitable Returns | 18.47% |
| Number Unprofitable Returns | 331 |
| Percent Unprofitable Returns | 81.53% |
| Profitable to Unprofitable Returns Ratio | 0.23 |
| VERV Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $736,981,000 | Price to Sales | 1,294.41 |
| Earnings per Share | $-3.0800 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.542 |
| PRICE DATA | |
| 52 Week High | $24.69 |
| 52 Week Low | $8.22 |
| Analyst Target Price | $46.44 |
| 50-Day Moving Average | $12.12 |
| 200-Day Moving Average | $15.8 |
| FINANCIAL DATA | |
| Revenue per Share | $0.123 |
| Revenue | $7,626,000 |
| Profit Margin | 0% |
| Return on Equity | -0.382% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
VERV Compare Returns with S&P 500
VERV Trendline Chart